证券代码：603083 证券简称：剑桥科技 公告编号：临 2025-046 上海剑桥科技股份有限公司 特别提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 按照中国证券监督管理委员会《上市公司募集资金监管规则》《上海证券交 易所上市公司自律监管指引第 1 号——规范运作》以及《上海证券交易所上市公 司自律监管指南第 1 号——公告格式》的相关规定，上海剑桥科技股份有限公司 （以下简称"公司"或"剑桥科技"）就 2025 年上半年度（以下简称"半年度" 或"报告期"）募集资金存放、管理与使用情况作如下专项报告： 一、募集资金基本情况 （一）实际募集资金金额、资金到位情况 根据公司 2020 年第二次临时股东大会决议，并经中国证券监督管理委员会 《关于核准上海剑桥科技股份有限公司非公开发行股票的批复》 （证监许可〔2020〕 资金总额人民币 749,999,993.76 元。公司委托中信证券股份有限公司（以下简称 "中信证券"）代收募股缴款，实际代收到缴纳的募集资金净额合计人民币 印 花 税 等 其 他 发 行 费 用 人 民 ...

Core Points - The report details the fundraising activities and usage of funds by Shenzhen Biyimi Microelectronics Co., Ltd. for the first half of 2025, ensuring compliance with relevant regulations and protecting investor interests [1][2][4] Fundraising Overview - The company raised a total of RMB 95,201.58 million by issuing 17,262,300 shares at RMB 55.15 per share, with a net amount of RMB 86,077.79 million after deducting issuance costs [1] - As of June 30, 2025, the total actual received fundraising amount was RMB 879,222,196.04, with a remaining balance of RMB 218,892,997.78 in the fundraising account [2][4] Fund Usage and Surplus - Cumulative direct investment in fundraising projects amounted to RMB 395,212,306.06, with RMB 69,953,204.26 invested in the current period [2][4] - The company has permanently supplemented working capital with RMB 167,529,096.32 from excess fundraising, and repurchased shares worth RMB 47,364,750.01 [4][6] Fund Management - The company has established a dedicated account storage system for fundraising, ensuring compliance with laws and regulations, and has signed multiple tripartite and quadripartite supervision agreements with banks and underwriters [1][2] - As of June 30, 2025, there were no outstanding financial products held, and all idle funds were managed effectively to generate returns [4][6] Project Status and Adjustments - There were no changes to the fundraising investment projects as of June 30, 2025, and no external transfers or replacements of fundraising projects occurred [5][6] - The company has adjusted the internal investment structure and extended the expected operational dates for certain projects, including the power management series control chip development project and the motor drive control chip development project, to May 2027 [5][6] Compliance and Disclosure - The company has adhered to all relevant laws and regulations regarding the use and disclosure of fundraising, ensuring timely and accurate reporting of fundraising storage and usage [5][6]

Fundraising Overview - The company raised a total of RMB 1,640.03 million by issuing 35.56 million shares at a price of RMB 46.12 per share, with net proceeds after expenses amounting to RMB 1,487.48 million [1][2] - As of June 30, 2025, the balance in the fundraising special account was RMB 187.55 million [1][3] Fund Utilization - The company utilized RMB 669.85 million for fundraising projects and permanently supplemented working capital with RMB 553.53 million from oversubscribed funds [1][4] - The company has not used idle fundraising funds to temporarily supplement working capital during the reporting period [2][4] Cash Management - The company approved the use of up to RMB 900 million of temporarily idle fundraising funds for cash management, ensuring that it does not affect project progress or operational safety [2][3] - A total of RMB 125 million was invested in high-safety, high-liquidity financial products [3][6] Project Investment Status - The company reported that there were no changes in the use of fundraising projects during the reporting period [4][6] - The high-end electronic materials production project and the semiconductor packaging materials project have specific investment amounts and progress, with the latter's investment amount adjusted from RMB 111.66 million to RMB 62.42 million [5][6] Oversubscription Fund Usage - The company permanently supplemented working capital with RMB 147.53 million from oversubscription funds during the reporting period [4][5] - There were no oversubscription funds used for ongoing or new projects, including asset acquisitions [4][5]

Summary of Key Points Core Viewpoint The report outlines the management, storage, and usage of the funds raised by Guangdong Leshi Medical Electronics Co., Ltd. for the first half of 2025, detailing the total amount raised, the current balance, and the specific projects funded. Fundraising Overview - The company raised a total of RMB 385,356,068.13 by issuing 23,998,780 shares at a price of RMB 16.48 per share to 14 specific investors [1][2] - As of the end of 2024, the balance in the fundraising special account was RMB 190,328,551.27, with RMB 9,537,660.29 used in the current year, leaving a balance of RMB 182,230,103.57 as of June 30, 2025 [2][5] Fund Management - The company has established a fundraising management system to enhance the efficiency of fund usage, complying with relevant regulations [2][3] - Funds are stored in special accounts at various banks, including China Construction Bank and Bank of China, specifically for the purpose of managing the raised funds [3][4] Fund Usage - The actual usage of the raised funds for the first half of 2025 is detailed in an attached table, with no changes in project implementation locations or methods reported [7][8] - The company has approved the use of up to RMB 180 million of idle funds for cash management, investing in safe and liquid financial products [7][8] Project Adjustments - The company has decided to extend the timeline for certain projects, such as the "Smart Blood Glucose Monitoring Product Industrialization Project," to October 31, 2026, due to market conditions and operational needs [8][10] - The remaining RMB 5,627.60 million from the "TWS Earphone Production Line Construction Project" will be used for permanent working capital [10][12] Compliance and Reporting - The company confirms that there are no issues with the disclosure of fundraising usage, and all activities comply with regulatory requirements [8][9] - The report was approved by the board of directors on August 14, 2025 [8]

Fundraising Overview - The company raised a total of RMB 436,222,997.10 as of June 30, 2025, from non-public stock issuance, with net proceeds amounting to RMB 423,958,661.65 after deducting underwriting fees of RMB 8,350,195.56 [1][2] - The company also conducted a simplified procedure for issuing stocks to specific targets, raising RMB 227,390,093.92, with a net amount of RMB 222,237,302.60 after deducting issuance costs of RMB 5,152,791.32 [2][3] Fund Management - The company has implemented a special account storage system for the raised funds, ensuring that the funds are managed and used specifically for their intended purposes [3][4] - As of June 30, 2025, the balance in the special account for the non-public issuance was RMB 415,201.13, while the balance for the simplified issuance was RMB 830,942.04 [5][6] Fund Usage - The company temporarily used RMB 70,000,000 of idle funds to supplement working capital, with a commitment to return the funds within 12 months [2][5] - The company has not engaged in cash management with idle funds or used excess funds for permanent working capital or loan repayments during the reporting period [6][7] Project Changes - The company approved a change in the use of funds from the "Annual Production of 68 million square meters of electronic materials expansion project" to the "Annual Production of 86 million square meters of electronic materials technological transformation project," reallocating RMB 171,397,100 [8][12] Compliance and Reporting - The company has adhered to the regulations set forth by the China Securities Regulatory Commission and the Shanghai Stock Exchange regarding the management and use of raised funds, ensuring legal and effective usage [7][14] - There were no significant issues in the usage and disclosure of raised funds during the reporting period [7][14]

Fundraising Overview - The company raised a total of RMB 61,198.32 million from its initial public offering, after deducting issuance costs of RMB 4,321.68 million [1] - As of June 30, 2025, the company has unused and idle raised funds totaling RMB 46,899.93 million, which includes interest and investment income [2][12] - The balance of the unused raised funds consists of RMB 8,360.32 million in excess funds and RMB 16,686.09 million in idle funds [2][12] Fund Management and Usage - The company has established special accounts for the management of raised funds, ensuring strict approval procedures for their usage [2] - The company has invested RMB 4,900.00 million of excess funds into its wholly-owned subsidiary, Guangxi Langke Technology Investment Co., Ltd., for the construction of the Langke International Storage Technology Industrial Park [2][3] - The company has signed tripartite supervision agreements with banks and sponsors to regulate the management and usage of raised funds [2][3] Changes in Fund Usage - The company has decided to terminate several fundraising projects, including the "Patent Application, Maintenance, and Operation Project" and the "Flash Application and Mobile Storage Technology Research Platform Expansion Project" due to changes in market conditions and strategic alignment [16][17] - The company has adjusted the implementation content and progress of certain projects, extending the construction period to December 1, 2015, to better align with operational needs [15][18] Financial Management - The company has continued to use excess and idle funds for cash management, investing in low-risk financial products with high liquidity [10][11] - As of June 30, 2025, the company has RMB 46,800.00 million in financial products that have not yet matured [11] Issues Identified - The company identified several instances where funds were improperly paid from the fundraising account, including payments for patent fees and legal fees, which have since been reimbursed [5][6][13] - The company has acknowledged that the actual investment in fundraising projects is only 21.8% of the expected total, indicating a significant delay in project execution [9][18]

证券代码：603456 证券简称：九洲药业 公告编号：2025-049 浙江九洲药业股份有限公司 关于公司 2025 年半年度募集资金存放与使用情况的 专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 为了规范募集资金的管理和使用，提高资金使用效率，保护投资者权益，浙 江九洲药业股份有限公司（以下简称"公司"）根据中国证券监督管理委员会《上 市公司募集资金监管规则》及《上海证券交易所上市公司自律监管指引第 1 号— —规范运作》及相关格式指引的规定，将本公司 2025 年半年度募集资金存放与 使用情况专项报告公告如下： 一、募集资金基本情况 (一) 2020 年非公开发行募集资金情况 经中国证券监督管理委员会《关于核准浙江九洲药业股份有限公司非公开发 行股票的批复》 （证监许可[2021]97 号）核准，公司非公开发行人民币普通股（A 股 ） 股 票 26,171,159 股， 发 行价格 为 38.21 元 /股，募 集资金 总额为人 民 币 集资金净额为人民币 990,619,373.71 元。上述募集资金到位情况 ...

Core Viewpoint - The report outlines the fundraising activities and usage of funds by Hangzhou Changchuan Technology Co., Ltd. for the first half of 2025, detailing the amounts raised, allocated projects, and changes in project funding [1][2][4]. Fundraising Overview - In 2021, the company raised a total of RMB 371.80 million by issuing 8,126,775 shares at RMB 45.75 each, with a net amount of RMB 364.71 million after deducting underwriting fees [1]. - In 2023, the company raised RMB 276.70 million by issuing 8,415,450 shares at RMB 32.88 each, with a net amount of RMB 271.98 million after deducting related fees [2]. Fund Usage and Management - As of June 30, 2025, the net amount of funds raised was RMB 362.46 million, with cumulative project investments of RMB 332.25 million and net interest income of RMB 2.03 million [2][5]. - The company has established dedicated bank accounts for fundraising, ensuring compliance with regulatory requirements and protecting investor interests [8][7]. Project Investment Status - The funds have been allocated to various projects, including the development and industrialization of probe stations and sorting machines, with specific amounts and progress detailed in the report [9][10]. - The probe station project has faced delays, with the expected completion date extended to December 31, 2025, due to technical challenges and market conditions [11][18]. Changes in Project Funding - The company decided to reallocate RMB 50 million from the probe station project to the high-end semiconductor manufacturing base project, reflecting a strategic shift based on market dynamics [16][20]. - The sorting machine project has also seen changes in its implementation structure, with the addition of EXIS TECH SDN BHD as a project partner and a change in the project location to Sichuan Province [12][14]. Financial Management - The company has utilized temporary idle funds for operational liquidity, with a total of RMB 74 million used for this purpose, which has been returned within the stipulated timeframe [19][22]. - The report indicates that the company has maintained strict adherence to its fundraising management protocols, ensuring transparency and accountability in fund usage [7][8].

Summary of Key Points Core Viewpoint - The report details the fundraising activities and the usage of raised funds by Shandong LianKe Technology Co., Ltd., highlighting the amounts raised, their allocation, and the current status of these funds as of March 31, 2025 [1][2]. Fundraising Overview - The total net amount raised from the initial public offering (IPO) was RMB 596,312,839.61 after deducting issuance costs of RMB 52,972,160.39 [2]. - The company was also approved to raise RMB 265,472,460.69 through a simplified procedure for a specific audience, with all funds received by June 27, 2023 [2]. Fund Usage and Balance - The net amount from the IPO was allocated as follows: - Pre-investment project replacement: RMB 160,118,544.89 - Post-investment project replacement: RMB 169,401,612.76 - Bank loan repayment: RMB 120,000,000.00 - Working capital: RMB 124,972,046.07 - Total interest income: RMB 14,990,416.15 - Remaining balance as of March 31, 2025: RMB 36,811,052.04 [2][3]. - For the funds raised through the simplified procedure, the allocations were: - Pre-investment project replacement: RMB 42,882,174.99 - Post-investment project replacement: RMB 205,344,603.35 - Total interest income: RMB 6,662,477.79 - Remaining balance as of March 31, 2025: RMB 23,908,160.14 [2][3]. Fund Management - The company has established a fundraising management system to ensure compliance with relevant laws and regulations, including the storage of funds in dedicated bank accounts under a tripartite supervision agreement [4][5]. Investment Project Status - There were no changes or transfers in the investment projects funded by the raised capital [6]. - The actual investment amounts for various projects differed from the committed amounts, with reasons provided for discrepancies, such as ongoing construction or market conditions affecting project timelines [8][9]. Project Benefits and Performance - The report includes a table detailing the benefits realized from the investment projects, with some projects unable to be individually assessed for profitability due to their nature [9][10]. - The "10,000 tons/year high-dispersed silica project" and the "10,000 tons/year high-pressure cable shielding material project" are highlighted, with the latter expected to generate significant profits once fully operational [10][11]. Idle Funds - The company has not utilized idle funds for purposes other than those specified in the fundraising commitments [11].

Core Viewpoint - The company has completed the convertible bond fundraising project and plans to permanently supplement its working capital with the remaining funds of 60,787,077.87 yuan, which includes cash management income and interest [1][4][6]. Summary by Sections Fundraising Project Completion - The company held a board meeting on July 3, 2025, to approve the conclusion of the convertible bond fundraising project, which has reached its intended operational status [1][7]. - The total amount raised through the convertible bonds was 285 million yuan, with a net amount of 279.79889 million yuan after deducting issuance costs [2][4]. Fund Management and Usage - A special account was established for the management of the raised funds, and a tripartite supervision agreement was signed with relevant parties [3][5]. - As of July 3, 2025, the remaining funds in the special account amounted to 60,787,077.87 yuan, representing 21.73% of the total raised funds [4][5]. Reasons for Fund Surplus - The surplus funds resulted from careful resource allocation and cost control during the project, as well as reduced material and funding needs due to a decline in factory order volumes [5][6]. - The company also achieved cash management income from idle funds, enhancing the efficiency of fund usage [5][6]. Future Use of Surplus Funds - The company intends to use the surplus funds to permanently supplement its working capital, which will support ongoing and future business operations [6][7]. - The decision to use the surplus funds does not alter the intended use of the raised funds and complies with relevant regulations [6][7]. Approval Process - The board's audit committee reviewed and approved the proposal to conclude the fundraising project and use the surplus funds, which will be submitted for shareholder approval [6][7][8].